The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
CHAI's Vaccines Program
Immunization is one of the most successful public health interventions in history. National immunization programs reach >100 million infants every year and have averted globally, two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974, whilst the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1 million lives per year. Furthermore, great advances in discovering and financing new vaccines provide a great opportunity for countries to further reduce the burden of disease due to virus such as the human papillomavirus (HPV). Despite these successes, 1.5 million children still die each year of vaccine-preventable diseases, many of them in low-income countries, as immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative has worked to save lives and reduce the burden of vaccine-preventable-diseases by improving access to immunization services in resource-limited setting, by strengthening national immunization programs, and by leveraging its experience working in low income countries to improve the global immunization ecosystem. CHAI's vaccine program works closely with the national immunization programs in 11 focus countries - Cameroon, Ethiopia, India, Indonesia, Kenya, Lao PDR, Lesotho, Nigeria, Tanzania, Uganda and Vietnam. CHAI also engages with key global stakeholders such as Gavi, WHO, UNICEF and BMGF to inform global policies and practices.
CHAI is pursuing six complementary strategic goals as part of its vaccine strategy:
Once countries have an average GNI/capita of $1,580 over 3 consecutive years, they begin the Gavi Transition process where over a five year time-period they bear a greater share of the cost of their immunization programs until they are fully self-financing. When countries transition out of Gavi support, they are expected to have successfully expanded their national immunization programmes with critical life-saving vaccines. In addition, robust systems and decision-making processes should also be in place to sustain current and new vaccines post-transition with high and equitable coverage. Countries approaching or currently in transition thus need to think strategically about their financial planning, which new vaccines to introduce, and to plan and mobilize domestic and external resources early to ensure those new vaccine costs can be sustained post-transition. To address these challenges, CHAI will be working with the governments in Vietnam, Lao PDR, Indonesia, Kenya, and Nigeria to sustain high immunization coverage, while effectively deploying the limited amount of Gavi support they have before it phases out and ensure high risks and dependencies at the national and subnational level are addressed.
PNG is another country that is facing significant challenges as it continues to transition from Gavi support with important gaps in coverage and equity for immunization at the national and provincial level. CHAI will develop potential scope for support to the PNG government in transitioning from Gavi support. CHAI’s long-term engagement in PNG, as the 12th and the newest program country in vaccines will be based on the scoping exercise and discussions with the government and donor.
CHAI’s PNG office opened in 2006 and has been a highly recognized partner of the HIV program. Since its inception, CHAI PNG supported the implementation of Prevention, Care and Treatment for the National HIV Program both at the national and sub-national level with a goal to build a sustainable HIV program and ensure capacity building of government human resources in PNG. Recently, CHAI PNG has ceased its HIV work and is working toward establishing newer health programs in the country. CHAI PNG currently does not have a Vaccines Delivery team. The Program Manager will be the first senior member of the team and will have to work closely with the PNG Country Director.
 Gavi, Eligibility and transition policy (https://www.gavi.org/about/programme-policies/eligibility-and-transition/)
CHAI PNG is looking for a Program Manager to join the team to lead the vaccines scoping work in PNG, beginning as a six-month project which could be extended as longer-term support to PNG MOH pending a decision from CHAI and the donor. The goal of this work will be to identify gaps and needs that are emerging as PNG is transitioning from Gavi support and to develop potential scope of support for CHAI to implement as part of its Gavi Transition support to the PNG MOH.
We are seeking a highly motivated individual with exceptional qualitative and quantitative analytical abilities, and leadership and communication skills. The Program Manager must be able to function independently and flexibly and have a strong commitment to excellence. Successful candidates demonstrate resourcefulness, responsibility, tenacity, independence, work ethic and emotional intelligence.
The successful candidate will work with the Global Vaccines team as well as with the CHAI PNG country leadership team on the following roles and responsibilities, but not only limited to the following: